Bone morphogenetic protein antagonist and uses thereof
US8383349B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2008 |
| Grant date | Feb 26, 2013 |
| Priority date | — |
| Expiry date | Sep 8, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of proteins that are differentially expressed in tumor associated stromal cells, as compared to normal stromal, as biomolecular targets for tumor treatment therapies. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.